BioSpace News Archive

Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced that during the annual shareholders meeting, Axel-Sven Malkomes and Donald Bergstrom, M.D., Ph.D., have been appointed as Directors of the Company’s Board of Directors, effective immediately.

Novavax, Inc. (Nasdaq: NVAX), today participated in the U.S. Food and Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee’s (VRBPAC) meeting which resulted in a 19-2 vote to recommend inclusion of a SARS-CoV-2 Omicron component for COVID-19 booster vaccines in the U.S. beginning this fall.

According to Vision Research Reports, The global perfusion system market was valued at USD 1.2 billion in 2021 and is projected to be worth around USD 1.89 billion by 2030, expanding at a compound annual growth rate (CAGR) of 5.2% from 2022 to 2030.

According to Vision Research Reports, the audiology devices market was valued at USD 11.7 billion in 2021 and it is predicted to surpass around USD 19.6 billion by 2030 with a CAGR of 5.9% from 2022 to 2030.

The global Infantile Spasms Therapeutics market size is projected to reach US$ 182.4 million by 2028, from US$ 142 million in 2021, at a CAGR of 3.6% during 2022-2030.

The global Human Prothrombin Complex market size is estimated to be worth US$ 1577 million in 2021 and is forecast to a readjusted size of US$ 3473.8 million by 2028 with a CAGR of 11.8% during the forecast period 2022-2030.

The global Contrast Medium market size is estimated to be worth US$ 5842.1 million in 2021 and is forecast to a readjusted size of US$ 7925.5 million by 2028 with a CAGR of 4.4% during the forecast period 2022-2030.

The global Urokinase market size is estimated to be worth US$ 45 million in 2021 and is forecast to a readjusted size of US$ 64 million by 2028 with a CAGR of 5.2% during the forecast period 2022-2030.

The global Cancer Treatment Drugs market size is estimated to be worth US$ 178880 million in 2021 and is forecast to a readjusted size of US$ 325040 million by 2028 with a CAGR of 8.8% during the forecast period 2022-2030.

The global Glucagon market size is estimated to be worth US$ 556 million in 2021 and is forecast to a readjusted size of US$ 845.7 million by 2028 with a CAGR of 6.1% during the forecast period 2022-2030.